Jennison Associates
LLY icon

Jennison Associates’s Eli Lilly LLY Stock Holding History

Jennison Associates’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-260,000
Closed -$19.1M – 733
2016
Q4 		$19.1M Buy
260,000
+130,000
+100% +$9.68M 0.02% 415
2016
Q3 		$10.4M Hold
130,000
– – 0.01% 471
2016
Q2 		$10.2M Buy
+130,000
New +$9.79M 0.01% 465

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jennison Associates's LLY Position: Q2 2026 in Review

Jennison Associates increased its Eli Lilly (LLY) stake by 7.9% in Q2 2026, buying an estimated $409M and bringing the position to 5,461,416 shares worth $6.55B. The position accounts for 3.93% of the portfolio, ranked #6.

Jennison Associates first reported a position in LLY in Q3 2013 and has held it in 51 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Jennison Associates held 5,461,416 shares of Eli Lilly worth $6.55B as of Q2 2026.
  • Jennison Associates bought 400,538 Eli Lilly shares in Q2 2026, an estimated $409M.
  • Eli Lilly made up 3.93% of Jennison Associates's portfolio in Q2 2026, its #6 holding.
  • Jennison Associates first reported a position in Eli Lilly in Q3 2013 and has held it in 51 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Jennison Associates's 13F filing for Q2 2026, filed 3 Aug 2026.